Driehaus Capital Management LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 938206
Chicago, IL
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$241,866,078
+$9,566,191 QoQ
Shares Held
6,463,551
+1.1% QoQ
Ownership
6.09%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#5
of 266 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. CRNX ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
6,845,276 | $322,001,783 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
959,048 | $321,079,679 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
4,418,557 | $266,704,100 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,799,166 | $248,509,957 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
6,463,551 | $241,866,078 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
1,740,101 | $230,963,605 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
4,728,623 | $192,123,952 | |
| 8 | SEPN |
Septerna, Inc.
|
4,433,058 | $148,463,112 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $241,866,078 | 6,463,551 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $232,299,887 | 6,395,922 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $232,299,887 | 6,395,922 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $297,349,297 | 6,387,740 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $269,959,181 | 6,481,613 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $184,064,719 | 6,400,025 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $209,286,313 | 6,239,902 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $313,990,045 | 6,141,014 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $300,736,172 | 5,885,248 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $273,764,228 | 6,112,173 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $244,642,962 | 5,226,297 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $179,321,670 | 5,039,957 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $152,634,215 | 5,132,287 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $95,471,545 | 5,298,088 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $84,949,675 | 5,289,519 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $102,932,815 | 5,624,744 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $110,611,655 | 5,631,958 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $102,098,660 | 5,474,459 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $108,521,085 | 4,944,013 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $136,187,255 | 4,793,638 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $63,118,677 | 2,998,512 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $51,042,501 | 2,707,825 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $30,616,352 | 2,003,688 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $20,515,460 | 1,453,966 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,708,774 | 874,842 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,536,070 | 886,762 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||